Protocol No.: NRG-BR003

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Principal Investigator
Kurian, Sobha; Osman, Salman; Shah, Nik; Soltani, Sanaz
III (Cancer Control)
Age Group
Applicable Disease Site
Breast Cancer
Participating Institutions
Berkeley Medical Center
Camden Clark Memorial Hospital
Mary Babb Randolph Cancer Center
United Hospital Center
Renee Stevenson, RN
Phone: +1 304-424-2585
Sabrina Loudin, RN
Research Nurse
Phone: +1 304-293-6066
Christa Boice, RN
Research Nurse
Phone: +1 304-420-7132
Valli White, RN
Research Nurse
Phone: +1 304-264-1220
Emily Hawkins, BSN
Research Nurse
Phone: +1 304-293-7375

View on